<DOC>
	<DOC>NCT00134810</DOC>
	<brief_summary>The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one's type of upper back pain. The study will also examine the side effects of this treatment and its overall effect on one's disorder.</brief_summary>
	<brief_title>Study to Assess the Efficacy and Safety of DysportÂ® in Upper Back Myofascial Pain Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Moderatesevere pain in upper back Myofascial pain syndrome for more than 6 months Active trigger points in upper back Fibromyalgia and other nonmyofascial pain conditions of upper back Duration of myofascial pain syndrome no longer than 24 months Steroid injections during previous 3 months Anaesthetic injection at trigger points during previous 1 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Myofascial pain syndrome</keyword>
</DOC>